248 related articles for article (PubMed ID: 28605317)
1. Rationalized Insights on Causes of Rheumatoid Arthritis in the Elderly and Women: Special Emphasis on Treatment Strategies.
Srivastava S; Patel S; Singh D; Singh MR
Crit Rev Ther Drug Carrier Syst; 2017; 34(2):97-147. PubMed ID: 28605317
[TBL] [Abstract][Full Text] [Related]
2. Targeted drug-delivery systems in the treatment of rheumatoid arthritis: recent advancement and clinical status.
Gorantla S; Singhvi G; Rapalli VK; Waghule T; Dubey SK; Saha RN
Ther Deliv; 2020 Apr; 11(4):269-284. PubMed ID: 32434463
[TBL] [Abstract][Full Text] [Related]
3. Scleroderma: An insight into causes, pathogenesis and treatment strategies.
Singh D; Parihar AK; Patel S; Srivastava S; Diwan P; Singh MR
Pathophysiology; 2019 Jun; 26(2):103-114. PubMed ID: 31130325
[TBL] [Abstract][Full Text] [Related]
4. Novel drug delivery systems for NSAIDs in management of rheumatoid arthritis: An overview.
Thakur S; Riyaz B; Patil A; Kaur A; Kapoor B; Mishra V
Biomed Pharmacother; 2018 Oct; 106():1011-1023. PubMed ID: 30119166
[TBL] [Abstract][Full Text] [Related]
5. Natural Products for the Treatment of Autoimmune Arthritis: Their Mechanisms of Action, Targeted Delivery, and Interplay with the Host Microbiome.
Dudics S; Langan D; Meka RR; Venkatesha SH; Berman BM; Che CT; Moudgil KD
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149545
[TBL] [Abstract][Full Text] [Related]
6. A Review on Rheumatoid Arthritis Interventions and Current Developments.
Khanna N; Kumar A; Pawar SV
Curr Drug Targets; 2021; 22(4):463-483. PubMed ID: 33243118
[TBL] [Abstract][Full Text] [Related]
7. Utilization of nanoparticle technology in rheumatoid arthritis treatment.
Dolati S; Sadreddini S; Rostamzadeh D; Ahmadi M; Jadidi-Niaragh F; Yousefi M
Biomed Pharmacother; 2016 May; 80():30-41. PubMed ID: 27133037
[TBL] [Abstract][Full Text] [Related]
8. Drug Delivery System Approaches for Rheumatoid Arthritis Treatment: A Review.
Garhwal A; Kendya P; Soni S; Kori S; Soni V; Kashaw SK
Mini Rev Med Chem; 2024; 24(7):704-720. PubMed ID: 37711105
[TBL] [Abstract][Full Text] [Related]
9. Current understanding of rheumatoid arthritis therapy.
Colmegna I; Ohata BR; Menard HA
Clin Pharmacol Ther; 2012 Apr; 91(4):607-20. PubMed ID: 22357455
[TBL] [Abstract][Full Text] [Related]
10. Current Developments in Therapeutic Drug Targeting for the Management of Rheumatoid Arthritis: An Emerging Paradigm.
Pai DR; Venkatesh MP; Kumar TMP
Crit Rev Ther Drug Carrier Syst; 2019; 36(6):485-536. PubMed ID: 32421953
[TBL] [Abstract][Full Text] [Related]
11. Polymeric Micelles for the Treatment of Rheumatoid Arthritis.
Yun L; Shang H; Gu H; Zhang N
Crit Rev Ther Drug Carrier Syst; 2019; 36(3):219-238. PubMed ID: 31679247
[TBL] [Abstract][Full Text] [Related]
12. Move to Nano-Arthrology: Targeted Stimuli-Responsive Nanomedicines Combat Adaptive Treatment Tolerance (ATT) of Rheumatoid Arthritis.
Liu L; Guo W; Liang XJ
Biotechnol J; 2019 Jan; 14(1):e1800024. PubMed ID: 30221835
[TBL] [Abstract][Full Text] [Related]
13. Recent approaches for targeted drug delivery in rheumatoid arthritis diagnosis and treatment.
Pirmardvand Chegini S; Varshosaz J; Taymouri S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):502-514. PubMed ID: 29661045
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate in the Treatment of Psoriasis and Rheumatoid Arthritis: Mechanistic Insights, Current Issues and Novel Delivery Approaches.
Rajitha P; Biswas R; Sabitha M; Jayakumar R
Curr Pharm Des; 2017; 23(24):3550-3566. PubMed ID: 28571554
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology to advanced intra-articular drug delivery strategies: Unravelling rheumatoid arthritis.
Singh H; Dan A; Kumawat MK; Pawar V; Chauhan DS; Kaushik A; Bhatia D; Srivastava R; Dhanka M
Biomaterials; 2023 Dec; 303():122390. PubMed ID: 37984246
[TBL] [Abstract][Full Text] [Related]
16. Biomimetic hydroxyapatite as potential polymeric nanocarrier for the treatment of rheumatoid arthritis.
Ain Q; Zeeshan M; Khan S; Ali H
J Biomed Mater Res A; 2019 Dec; 107(12):2595-2600. PubMed ID: 31373751
[TBL] [Abstract][Full Text] [Related]
17. Lipid-based Vesicular Nanocargoes as Nanotherapeutic Targets for the Effective Management of Rheumatoid Arthritis.
Rahman M; Beg S; Sharma G; Saini S; Rub RA; Aneja P; Anwar F; Alam MA; Kumar V
Recent Pat Antiinfect Drug Discov; 2016; 11(1):3-15. PubMed ID: 27193030
[TBL] [Abstract][Full Text] [Related]
18. Stimuli-responsive Drug Delivery Systems as an Emerging Platform for Treatment of Rheumatoid Arthritis.
Xu XL; Lu KJ; Yao XQ; Ying XY; Du YZ
Curr Pharm Des; 2019; 25(2):155-165. PubMed ID: 30907308
[TBL] [Abstract][Full Text] [Related]
19. Role of Bioactive Compounds, Novel Drug Delivery Systems, and Polyherbal Formulations in the Management of Rheumatoid Arthritis.
Rana N; Gupta P; Singh H; Nagarajan K
Comb Chem High Throughput Screen; 2024; 27(3):353-385. PubMed ID: 37711009
[TBL] [Abstract][Full Text] [Related]
20. Treatment of rheumatoid arthritis: Unraveling the conundrum.
Zampeli E; Vlachoyiannopoulos PG; Tzioufas AG
J Autoimmun; 2015 Dec; 65():1-18. PubMed ID: 26515757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
